weight loss drug news today glp-1 Half of users ditch their injections — and some are turning to other weight-loss methods instead New warning issued over compounded

DiMarchi had just left the company and become a professor of chemistry at Indiana University, and also wanted to develop obesity treatments that combine multiple drug targets

The starting dose of 2.5 mg is not considered therapeutic for weight loss

See if You Qualify The Ozempic Lawsuit is an active lawsuit See If You Qualify Ozempic and Gastroparesis Overview Litigation is pending against Novo Nordisk, the manufacturer of Ozempic, for allegedly not properly warning about the potentially severe gastrointestinal side effects related to its GLP-1 drugs

The most recent formulary shows that Ozempic is covered, but it requires prior authorization

GLP-1 receptor agonists have great therapeutic potential for treating diabetes and obesity

Researchers in JAMA Network Open reviewed the total cost of producing GLP-1 medications (as well as insulin and another classes of medicines used for diabetes) with an eye toward establishing a resource-based price so that these medications could be used to treat obesity and diabetes in low and middle income countries, where noncommunicable diseases such as heart disease and diabetes take a larger toll each year